zKirkland’s Q2 EPS $(1.31) Misses $(0.87) Estimate, Sales $102.10M Beat $97.17M Estimate
Kirkland's (NASDAQ:KIRK) reported quarterly losses of $(1.31) per share which missed the analyst consensus estimate of $(0.87) by 50.57 percent. This is a 13000 percent decrease over losses of $(0.01) per share from the
Earnings Scheduled For August 30, 2022
Companies Reporting Before The Bell
• Photronics (NASDAQ:PLAB) is likely to report quarterly earnings at $0.50 per share on revenue of $210.00 million.
Preview: Kirkland’s’s Earnings
Kirkland's (NASDAQ:KIRK) is set to give its latest quarterly earnings report on Tuesday, 2022-08-30. Here's what investors need to know before the announcement.
Analysts estimate that Kirkland's will report an earnings per share (EPS) of $-0.87.
This Biotechnology Stock Tumbled 37%; Here Are 70 Biggest Movers From Yesterday
Gainers
Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares climbed 135.9% to close at $2.17 on Thursday.
Kirkland’s Q2 2022 Earnings Conference Call On August 30, 2022 At 09:00 AM ET
Kirkland's (NASDAQ:KIRK) will host a conference call at 09:00 AM ET on August 30, 2022, to discuss Q2 2022 earnings results.
How to Attend Kirkland's (KIRK) Conference Call
Follow this link to access the live webcast.
Here’s How Much You Would Have Made Owning Kirkland’s Stock In The Last 15 Years
Kirkland's (NASDAQ:KIRK) has outperformed the market over the past 15 years by 1.06% on an annualized basis producing an average annual return of 8.35%. Currently, Kirkland's has a market capitalization of $65.67 million.
Why Plus Therapeutics Is Trading Higher By Over 50%, Here Are 50 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 297% to $3.66.